Kodiak Sciences (KOD) Preferred Stock Liabilities (2016 - 2018)
Kodiak Sciences (KOD) reported Preferred Stock Liabilities of $50.0 million for Q3 2018, little changed quarter-over-quarter from $50.0 million in Q4 2017.
Kodiak Sciences (KOD) Preferred Stock Liabilities (2016 - 2018) Analysis & Trends
Kodiak Sciences has reported Preferred Stock Liabilities for 3 years, with the latest figure at $50.0 million in Q3 2018.
- For the quarter ending Q3 2018, Preferred Stock Liabilities changed N/A year-over-year to $50.0 million; the trailing twelve-month figure through Sep 2018 stood at $50.0 million (changed N/A YoY), and the FY2017 full-year result was $50.0 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities for Q3 2018 stood at $50.0 million, roughly flat from $50.0 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $50.0 million in Q4 2016, with the low at $50.0 million in Q4 2016.
- Historically, Preferred Stock Liabilities has averaged $50.0 million across 3 years, with a median of $50.0 million in 2016.
- The largest YoY upside for Preferred Stock Liabilities was 0.0% in 2017 against a maximum downside of 0.0% in 2017.
- Kodiak Sciences' Preferred Stock Liabilities stood at $50.0 million in 2016, then changed by 0.0% to $50.0 million in 2017, then changed by 0.0% to $50.0 million in 2018.
- The last three Preferred Stock Liabilities figures came in at $50.0 million (Q3 2018), $50.0 million (Q4 2017), and $50.0 million (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 50.02 Mn |
| Dec 31, 2017 | 50.02 Mn |
| Dec 31, 2016 | 50.02 Mn |